Chest CT Prior to Stem Cell Transplant Beneficial for Spotting Abnormalities
FRIDAY, Feb. 24, 2023 (HealthDay News) — Pretransplant screening chest computed tomography (CT) is beneficial for identifying abnormalities before allogenic hematopoietic stem cell transplant (alloHSCT), according to a study published online Feb. 3 i…
Learn MoreAllogeneic Stem Cell Transplant Feasible for Leukemia in Elderly Patients
TUESDAY, Feb. 21, 2023 (HealthDay News) — In elderly adults aged 60 years and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), allogeneic hematopoietic stem cell transplant (HSCT) can be performed with acceptable overall sur…
Learn More10 Years on, Stem Cell Transplant May Have Cured Patient of HIV
MONDAY, Feb. 20, 2023 (HealthDay News) — A man who underwent a stem cell transplant to treat his cancer is showing “strong evidence” that the procedure also cured him of HIV — the latest in a handful of cases doctors have reported.The patient, a man…
Learn MoreStudy Looks at Clonal Hematopoiesis in Pediatric Cancer Survivors
FRIDAY, Feb. 10, 2023 (HealthDay News) — Clonal hematopoiesis (CH) occurs more often in pediatric cancer survivors than community controls, according to a study published online Feb. 8 in Cancer Discovery.Kohei Hagiwara, Ph.D., from St. Jude Children…
Learn MoreASA: Stem Cell Transplant Improves Vasculopathy in Sickle Cell Patients
THURSDAY, Feb. 9, 2023 (HealthDay News) — For adults with sickle cell disease (SCD), hematopoietic stem cell transplantation (HSCT) seems to improve or prevent development of vasculopathies, according to a study presented at the American Stroke Assoc…
Learn MoreASA: Stem Cell Transplant Improves Vasculopathy in Sickle Cell Patients
THURSDAY, Feb. 9, 2023 (HealthDay News) — For adults with sickle cell disease (SCD), hematopoietic stem cell transplantation (HSCT) seems to improve or prevent development of vasculopathies, according to a study presented at the American Stroke Assoc…
Learn MorePosoleucel Efficacious for Stem Cell Transplant Recipients
TUESDAY, Jan. 17, 2023 (HealthDay News) — For recipients of allogeneic hematopoietic cell transplantation (allo-HCT) with refractory viral infections/disease, the T-cell therapy posoleucel is well tolerated and effective, according to a study publish…
Learn MoreUna terapia con células madre quizá ralentice a la EM mejor que los fármacos, según un estudio
MIÉRCOLES, 28 de diciembre de 2022 (HealthDay News) — Un nuevo estudio amplía las evidencias de que las personas con esclerosis múltiple (EM) se pueden beneficiar de un tipo de trasplante de células madre, incluso los pacientes que están en una fase …
Learn MoreAutologous Hematopoietic Stem Cell Transplant Slows Disability Progression in MS
WEDNESDAY, Dec. 28, 2022 (HealthDay News) — For patients with active secondary progressive multiple sclerosis (SPMS), autologous hematopoietic stem cell transplantation (AHSCT) is associated with a slowing of disease progression compared with other a…
Learn MoreStem Cell Therapy May Slow MS Better Than Meds: Study
WEDNESDAY, Dec. 28, 2022 (HealthDay News) — A new study is adding to evidence that people with multiple sclerosis can benefit from a type of stem cell transplant — including some patients who are in a more advanced phase of the disease.The research …
Learn More